These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL; Algra A; van Gijn J Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415 [TBL] [Abstract][Full Text] [Related]
23. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284 [TBL] [Abstract][Full Text] [Related]
25. Improving the outcome of acute stroke management. Hennerici M Hosp Med; 1999 Jan; 60(1):44-9. PubMed ID: 10197098 [TBL] [Abstract][Full Text] [Related]
26. New pharmaceutical approaches to stroke prevention, treatment. Phillips P JAMA; 1999 Jun; 281(22):2075-6. PubMed ID: 10367806 [No Abstract] [Full Text] [Related]
27. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke? Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M; Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622 [TBL] [Abstract][Full Text] [Related]
28. Drug therapy in patients with recent stroke. Harper GD; Castleden CM Br Med Bull; 1990 Jan; 46(1):181-201. PubMed ID: 2405941 [TBL] [Abstract][Full Text] [Related]
29. Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps. Leader A; Ten Cate H; Spectre G; Beckers EAM; Falanga A Crit Rev Oncol Hematol; 2018 Dec; 132():76-88. PubMed ID: 30447929 [TBL] [Abstract][Full Text] [Related]
30. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]). Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959 [TBL] [Abstract][Full Text] [Related]
31. Protecting the brain and the heart: antithrombotic treatment in nonvalvular atrial fibrillation. Safouris A; Anagnostis P; Karlovasitou A; Karras S; Karagiannis A Angiology; 2014 May; 65(5):372-8. PubMed ID: 23620311 [TBL] [Abstract][Full Text] [Related]
32. Antithrombotic and thrombolytic therapy for ischemic stroke. Albers GW; Easton JD; Sacco RL; Teal P Chest; 1998 Nov; 114(5 Suppl):683S-698S. PubMed ID: 9822071 [No Abstract] [Full Text] [Related]
38. Gender differences in anticoagulation and antithrombotic therapy. Rauch U Handb Exp Pharmacol; 2012; (214):523-42. PubMed ID: 23027465 [TBL] [Abstract][Full Text] [Related]
39. [Therapy from the hemorheologic viewpoint. 1: Hemodilution and defibrinogenation]. Ernst E Fortschr Med; 1986 Jun; 104(21):423-6. PubMed ID: 3732982 [No Abstract] [Full Text] [Related]